New Delhi, June 9 -- India plans to introduce a minimum import price (MIP) for select pharmaceutical raw materials in a move to shield its domestic industry from a flood of cheap Chinese imports, two people directly involved in the process said, a step that will also shore up India's status as the world's largest supplier of generic drugs. India accounts for about a fifth of the global supply of generic drugs, manufacturing about 60,000 generic brands, across 60 categories. "The government is working on a plan to impose a minimum import price on all PLI-based pharmaceutical products. The plan is to protect the domestic industry so that they are able to continue to do the business and to make India self-reliant," said one of the two people mentioned above. P11...